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Objectives: The Rare Dementia Support (RDS) Impact study will be the first major
study of the value of multicomponent support groups for people living with or
supporting someone with a rare form of dementia. The multicentre study aims to
evaluate the impact of multicomponent support offered and delivered to people liv-
ing with a rare form of dementia, comprising the following five work packages (WPs):
(a) longitudinal cohort interviews, (b) theoretical development, (c) developing mea-
sures, (d) novel interventions, and (e) economic analysis.
Methods: This is a mixed-methods design, including a longitudinal cohort study
(quantitative and qualitative) and a feasibility randomised control trial (RCT). A cohort
of more than 1000 individuals will be invited to participate. The primary and second-
ary outcomes will be in part determined through a co-design nominal groups tech-
nique prestudy involving caregivers to people living with a diagnosis of a rare
dementia. Quantitative analyses of differences and predictors will be based on
prespecified hypotheses. A variety of quantitative (eg, analysis of variance [ANOVA]
and multiple linear regression techniques), qualitative (eg, thematic analysis [TA]), and
innovative analytical methods will also be developed and applied by involving the arts
as a research method.
Results: The UCL Research Ethics Committee have approved this study. Data collec-
tion commenced in January 2020.
Conclusions: The study will capture information through a combination of longitudi-
nal interviews, questionnaires and scales, and novel creative data collection methods.
The notion of “impact” in the context of support for rare dementias will involve theo-
retical development, novel measures and methods of support interventions, and
health economic analyses.
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1 | INTRODUCTION
“Rare dementias” are forms of dementia characterised by progressive
difficulties with cognitive symptoms other than memory and/or
occurring before the age of 65 (www.raredementiasupport.org).1
Non-Alzheimer or vascular causes may account for up to 25% of all
cases of dementia, but prevalence and incidence data are only avail-
able for some rare dementias (eg, frontotemporal dementia [FTD]:
15-22/100 000 and 2.7-4.1/100 000, respectively2), and the picture
is complicated by the clinical and pathological heterogeneity of condi-
tions (eg, approximately 80% of cases of the visual dementia posterior
cortical atrophy [PCA] are caused by [atypically distributed] Alzheimer
disease3,4). The rare dementias are proportionately more common in
individuals under 65 years old, but are by no means constrained to
this age group alone.1
Diagnoses of rare dementias are often delayed (eg, 30% will have
received a prior incorrect psychiatric diagnosis5), and an early-onset
(≤65 years of age) diagnosis raises additional challenges relating to
individual and family transitions (eg, work, retirement planning, and
care transitions6,7). Post diagnosis, many find that existing health,
social, and voluntary services do not cater adequately for their individ-
ual needs, and more specifically that established support groups are
often not particularly relevant to their situation owing to significant
differences compared with other group members in age, life situa-
tions, and symptoms. Despite high numbers nationally, there is not
the density of service needed within most regions to make indepen-
dent local condition-specific support groups viable.
The term “support group” is used variably, with groups varying in
structure, duration, and facilitation (professional, lay, or both). However, a
defining feature, as operationalised for systematic reviews,8 is the oppor-
tunity for people with or caring for someone with dementia to communi-
cate and interact socially, irrespective of content (exchanging ideas,
emotional support) or form of contact (face-to-face, phone, online).
A recent review of peer support models for dementia concluded
that while multicomponent support interventions improve carer well-
being in the wider population with dementia, the factors mediating
this are unclear.9 The PM's Challenge Implementation Plan10 also
states that evidence from the National Institute for Health Research
(NIHR)'s peer support network (PSN) demonstrator site scheme11
shows “support for carers can have a positive impact in reducing or
delaying people diagnosed with dementia entering residential care”
(p. 33). Computer-mediated interventions for informal carers may also
have positive effects upon levels of carer burden/stress, depression,
and anxiety12 opening up new technological avenues for connecting
with carers in situations where/when attendance at face-to-face
meetings may not be practical. Dementia support groups may also
yield a social value greater than the cost of investment (£1.17-£5.18
per £1 investment13), with benefits reported for people living with
dementia (eg, mental stimulation and a reduction in loneliness), their
carers (eg, reduction in stress and burden of care), and the volunteers
facilitating the sessions (increased knowledge). Other positive out-
comes reported for people living with a dementia (PLWD) include a
reduction in depression and improved quality of life and self-
esteem,14 and identification with others, commonality of experience,
and reciprocity of support.15
The current project capitalises on the collective experiences of
more than 1000 members of Rare Dementia Support (RDS). A vibrant
network of six condition-specific support groups, hosted by University
TABLE 1 A description of the conditions supported by Rare
Dementia Support
Support Group Description of Condition
Familial Alzheimer
disease (FAD)
An inherited form of typical Alzheimer
disease, caused by a faulty gene—
affecting people as young as 30
Frontotemporal
dementia (FTD)
A group of dementias predominantly




A group of dementias predominantly
affecting behaviour and personality.
Posterior cortical
atrophy (PCA)
A progressive condition predominantly
affecting visual and spatial perception.
Primary progressive
aphasia (PPA)
A group of dementias predominantly




A less common form of dementia that is
closely related to Parkinson disease,
predominantly affecting movement and
may include visual hallucinations.
Key Points
• The RDS Impact project will be the first major study of
the value of multicomponent support groups for people
living with or supporting someone with a rare form of
dementia.
• The study will capture information through a combination
of longitudinal interviews, questionnaires and scales, and
novel creative data collection methods.
• More than 1000 individuals located across the United
Kingdom and internationally who are members of Rare
Dementia Support will take part in the project.
• The project will explore the impact of multicomponent
support groups through five areas of enquiry
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College London (UCL) and attracting 60 new referrals per month, RDS
connects individuals affected by FTD (established in 1994), primary
progressive aphasia (PPA; est. 2005), PCA (est. 2007), and the directly
inherited conditions familial Alzheimer disease (FAD; est. 2010), famil-
ial FTD (fFTD; est. 2011) and dementia with Lewy bodies (DLB; est.
2018) (Table 1).
In addition to London-based, condition-specific meetings, there
are Carer and Bereaved carer groups (for carer members from across
the six conditions) and 26 regional groups from Cornwall to Mersey.
RDS also has a widespread international membership, including mem-
bers in Singapore, China, United States, Australia, and New Zealand.
Each group is multicomponent (capitalising on experiential and profes-
sional knowledge), open to all (PLWD, current and former carers
[at standard meetings and dedicated Bereaved carer meetings]), ongo-
ing (three to four meetings per year), multipurpose (psychoeducation
and emotional support), and multiformat (opportunities for PLWD and
carers to participate together and separately; mix of whole group
talks/Q&As average N = 40-80 members] and small group [N = 8-10]
discussions; face-to-face meetings plus phone/email support and
regional meetings). Meetings and newsletters are shaped by members
and the groups also provide opportunities to inspire, influence, and
participate in research. Unlike short-term groups and interventions,
the groups ensure continuity over years and even decades. This conti-
nuity reflects a culture and community of care, developing and sharing
collective knowledge about what works and when, retaining institu-
tional knowledge through many-to-many rather than solely one-to-
one relationships in a manner robust to staff and membership
changes. RDS provides a stable familiar platform of support that is
accessible in different ways over the long courses of people's demen-
tia journeys.
This study will investigate the impact and reach of mul-
ticomponent support offered and delivered to people living with a
rare form of dementia through five work packages (WPs) (see Boxes 1
and 2). The 5-year study (2019-2023) is led by UCL alongside collabora-
tors from Bangor University, Wales, and Nipissing University, Canada.
2 | METHODS AND STUDY DESIGN
The study is primarily a longitudinal mixed-methods investigation,
with some additional cross-sectional evaluations for theoretical and
measure development (see Box 2). Data collected from WP1 in the
longitudinal interviews will inform and contribute to analyses in WPs
2 to 5. A feasibility RCT will be carried out in WP4 to develop and test
novel online forms of support for people living with, caring for, or
working with someone living with a rare dementia.
2.1 | Participants
The main study population for RDS Impact will comprise more than
1000 individuals located across the United Kingdom and interna-
tionally who are members of RDS who have opted in to our mem-
bership database and, in doing so, have expressed an interest in
hearing about research opportunities. These individuals include peo-
ple living with a diagnosis of a rare form of dementia (eg, fFTD,
FTD, PCA, DLB, FAD, PPA, and young onset dementias), people
supporting or caring for people living with a rare form of dementia
(eg, relatives, friends, and professional carers), and professionals
who work with or have a professional interest in people affected by
a rare dementia.
2.2 | Predicted sample size
Approximately 92% of RDS members either live with a diagnosis of
a rare dementia or alongside someone with a rare form of demen-
tia. All will receive an invitation to take part in WP1. Based on the
high level of engagement from members in previous research stud-
ies, we anticipate a high response rate. In addition, we note that
while individuals may sign up to become a member of RDS, this
membership may represent a wider support network of relatives,
BOX 1 RDS Impact study objectives [Colour figure can be viewed at wileyonlinelibrary.com]
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friends, and professionals affiliated with the person living with a
rare dementia, and we will encourage RDS members to circulate
the research invitation to their relatives. To this end, if we approxi-
mate that each member represents a dyad (at minimum) and take
the predicted response rate into account, we predict our overall
sample size to increase accordingly. A large sample size facilitates
well-powered subanalyses in a group where research is traditionally
hampered by underpowered studies, with consequent potential for
type-II error.
Other potential participant groups who will be contacted will
comprise individuals who are affiliated with collaborating sites at Ban-
gor and Nipissing Universities by virtue of engaging in regional or
international support groups and/or by taking part in previous
research undertaken by the institutions.
Individuals who are participating in the study with a diagnosis of
dementia will have capacity to consent from the outset.
2.3 | Sampling approach
Purposive sampling will take place throughout the sampling and
subsampling process for WPs 2 to 4 in order to achieve as broad a
sample as possible (eg, incorporating different backgrounds and differ-
ent diagnoses of rare dementias). Participants' preferences will be
taken into account in accordance with the participants' convenience
and will be considered in line with the time commitment required to
avoid overburdening.
The majority of participants in this study will be recruited for bian-
nual interviews (as part of WP1) but may specify a wish to take part in
the other work packages over the course of the study (see Box 2).
2.4 | Methods
2.4.1 | Work package 1—longitudinal cohort study
This WP comprises a combination of cross-sectional and longitudinal
semistructured telephone/virtual (and, where appropriate, face-to-
face) interviews to establish the experiences and access to support in
relation to the diagnosis of a rare dementia (Box 3). Researchers will
gather quantitative and qualitative health and membership demo-
graphic data. A range of standardised measures will be used to charac-
terise interview themes (eg, health and care service use, resilience,
personal difficulties, and health/functional status). The interview con-
structs and measures will be derived based on the findings of a prelim-
inary consensus exercise involving RDS members as co-researchers
using the nominal groups technique.16 The interviews will also gather
data to inform WP3 (measure development) and understanding cur-
rent member use of online support to inform WP4 (eg, motivation to
use the internet, access, and/or barriers etc.)
BOX 2 RDS Impact: timeline and methodological outline for each work package [Colour figure can be viewed at wileyonlinelibrary.com]
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We will evaluate how membership and degree of involvement are
associated with primary (eg, QoL, connectedness, coping, knowledge
of condition, knowledge and use of appropriate services, stigma; to be
informed by WSs1-3) and secondary (eg, resilience, stigma, mental
health) outcomes over the course of the project.
Quantitative data will be summarised using statistics appropriate
to data characteristics, and precision of estimates will be expressed
using 95% confidence intervals. Analysis of variance (ANOVA) and
multiple linear regression techniques will be used as appropriate to
specific questions. Qualitative data will be interrogated using thematic
analysis17,18 of data from the open-ended questions to provide a
richer picture of experiences.
Findings from the quantitative and qualitative data collection will be
grouped in relation to timeframe to create disease staging documents.
These timeframes will be compared and contrasted with novel data-
driven computational event-based models of these sequences of events.
Innovative analytical methods will also be developed and applied
by involving the arts as a research method in dementias,19 examining
lived experience in a subset of approximately 10% of participants
including research poetry20 and developing visual responses (Visual
Routes) to personal experience over time.21,22 The research poem23
builds on traditional forms of thematic analysis18 and will be a powerful
tool to convey affective, social, and experiential aspects of group mem-
bership and caring over time. Our plan is to involve a subset of mem-
bers as co-researchers to interview a designated number of other group
members; their interviews will be used to jointly create research poems
based on verbatim accounts and identified TA themes. The poems will
reflect experiential accounts of members, rather than a more literary
use of the poem,20 research poems will contribute to WS2 and WS4
and will be used in interactive public engagement activities.
2.4.2 | Work package 2—theoretical development
Following a literature review, researchers will subsample members and
facilitators (and others, eg, commissioners, charity leads, referring pro-
fessionals) of 10 different support group meetings in order to develop
a theoretical understanding of the processes, contexts and people
involved in these groups using situational analysis (SA).24 SA has not, to
our knowledge, previously been used in dementia care research. SA
has its roots in grounded theory but goes beyond examining social pro-
cesses in order to develop “situational maps,” which centre on elucidat-
ing the key elements, materialities, discourses, structures, and
conditions that characterize the situation of inquiry (an RDS group),
rather than focusing only on individual participants through interviews.
Analysis of the data will inform and subsequently allow the
research team to establish a broad Theory of Change (ToC) of mul-
ticomponent support groups for people with rare dementia and
nested subtheories of change tailored to particular populations
(eg, genetically at risk individuals) and formats (eg, online support).
Broadly speaking, a ToC describes the causal assumptions specific to
an intervention's sequence of events or steps leading to impact (eg,
how did the support group contribute to positive changes in well-
being). A ToC is also valuable for the ongoing management and evalu-
ation of support groups and assessing their scalability.25
2.4.3 | Work package 3—measure development
Few outcome measures are designed specifically for people living
with rarer forms of dementia. Our lack of understanding of the
lived experience of people with these conditions also means that
this in-depth study of their experiences may bring to light topics,
issues, or concepts not previously considered in studies of people
with dementia more generally. Despite global interest in resilience
and health,26 there are no resilience outcome measures for people
living with dementia. Consequently, they cannot be considered as
one of the set of “core outcomes” proposed for dementia
research.27-29 This is an important area for further investigation if
we are to understand how the resilience of people living with
dementia can be enhanced by health, psychological, and social care
services or interventions. We describe below the framework for
developing a resilience measure, involving a subsample of up to
490 participants. For any further new measures prompted by par-
ticipant responses from WP1, a similar framework would be
adopted.
BOX 3 Breakdown of work package methodologies (see Section 2) [Colour figure can be viewed at wileyonlinelibrary.com]
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We will develop and test a resilience outcome measure for people
living with dementia, including those with a rare dementia (and proxy
response measure) that is appropriate for evaluating the impact of
health, psychological, and social care services and interventions.
Following a literature review to identify the components of resil-
ience as described by people living with dementia, researchers will
conduct qualitative interviews to explore what matters the most in
terms of the challenges experienced, strategies and resources for
dealing with challenges, and the endpoints that they would find most
meaningful (including data from WP1). A subsequent two-round Del-
phi survey of stakeholder groups will be undertaken to gain consensus
on the core components identified in previous steps of development.
Measurement items will be developed from the agreed conceptual
framework and appropriate response categories and question stems
identified. Items will be pretested with a small group of people living
with dementia, with subsequent revisions made in response to this
process. The penultimate stage will involve field testing and a prelimi-
nary evaluation of psychometric properties to identify and eliminate
items with poor psychometric performance, eg, through exploratory
factor analysis. Finally, a psychometric evaluation of the novel mea-
sure will take place.
Thematic analysis17,18 will explore the qualitative interviews to
inform the development of the theoretical framework. We will then
identify and eliminate items with poor psychometric performance by
conducting an exploratory factor analysis and investigate the accept-
ability, reliability, validity, and responsiveness of the reduced item
questionnaire. We will undertake convergent and discriminant validity
analysis and ensure internal consistency before evaluating the final
iteration of the developed measure.
2.4.4 | Work package 4—novel interventions
This work package will subsample participants, who will be involved in
developing a blended manualised intervention, with content informed
by a combination of (a) thematic analysis of WP1 data; (b) our ToC
arising from WP2; (c) 2018 NICE guidelines on interventions for
carers of people with dementia; (d) recent systematic reviews eluci-
dating the active components of online carer interventions,30
(e) evidence as to the support needs of carers of people with a rare
dementia; and (f) consultation with experts on the delivery and design
of online interventions and online support research. Thematic analysis
of responses from WP1 online intervention questions and focus
groups will be undertaken throughout the iterative intervention devel-
opment process.
We will enhance the accessibility of our intervention to those
with sensory impairment and disability by following web content
accessibility guidance31 and will build into the intervention an initial
consultation with a professional to support those with low computer
literacy.
Seventy-five participants will be invited to take part in a feasibility
study. Following consultation of demographic and premeasure infor-
mation (from WP1), participants will be randomized 2:1 to
intervention or treatment as usual (TAU) by an independent clinical
trials unit (North Wales Organisation for Randomised Trials in Health
and Social Care (NWORTH), Bangor) using Russell et al's dynamic
randomisation procedure.32 Researchers collecting the outcome mea-
sures and analysing the data will be blind to allocation.
Primary quantitative outcomes will include the acceptability
(percentage of participants completing intervention and percentage
of sessions attended) and feasibility (recruitment of an adequate
sample over the timeframe and retention rate in the study). Second-
ary outcome measures will include the outcome measures we would
use in a full trial and will be informed by WS2 (theoretical develop-
ment) and WS3 (measure selection and development). Constructs
measured may include depression, carer burden, quality of carer/
person with rare dementia (PWRD) relationship, quality of life, posi-
tive aspects of caring, and challenging behaviour of the PWRD and
resilience. A primary measure of effect (eg, carer well-being; EQ-
5D33) will be used for exploratory cost effectiveness analysis in
WP5. Scales (eg, the RUD34) will be used to capture service use
across different agencies including the NHS, local authority, and
third sector.
A “stop-go” measure for proceeding to a full trial will relate to our
success criterion: If 70% or more of recruited participants meet crite-
rion, proceed to roll out of trial; if it is 60% to 70%, consider a modi-
fied design to increase adherence; if it is less than 60%, do not
progress to a full trial using this method. Our second criterion for suc-
cess is to recruit our target sample size within the planned study time-
frame. We will report proportion of missing data on measures and use
this as an index of measure acceptability. Preliminarily analysis of
quantitative outcome measures will be undertaken using linear mixed
models to establish feasibility and estimate likely effect sizes. No
hypothesis testing will be undertaken, and all estimates will be pres-
ented with their associated 95% confidence intervals. Data analysis
will be supported by NWORTH.
All participants will complete a postintervention questionnaire
including open questions on barriers and facilitators. We will purpo-
sively sample 10 to 15 participants (we will include those who self-
identify as “non- expert” computer users as well as those with English
as a second language in order to examine acceptability of translation
tools) to take part in qualitative interviews. In line with process evalu-
ation guidance,35 implementation and potential mechanisms of impact
will be a focus as will intervention design and content.
2.4.5 | Work package 5—economic analysis
Using Markov modelling, we will use data from the previous WPs to
model the cost effectiveness of referral to multicomponent support
groups for people affected by rare dementias (PWRD and carers) over
a lifetime period and the exploratory cost effectiveness of the online
support intervention.
A systematic review and—where possible—meta-analysis will be
undertaken to establish the effectiveness of multicomponent support
groups. The systematic review protocol will be registered with
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PROSPERO. This will complement effectiveness data generated by
WP3 and WP4. Searches will be conducted in biomedical databases
such as MEDLINE, Cochrane Controlled Trials Database, EMBASE,
Clinicaltrials.gov, and the FDA and EMA websites to identify eligible
studies.
We will identify a primary measure of effect (eg, DEMQOL
[Dementia Quality of Life]36) in WP3 to enable exploratory cost effec-
tiveness analysis based on parameter data on service use and cost,
utilities, and other outcomes from WS1 and WS4. Data for parame-
ters of the economic model will be extracted using a standardised
template and an assessment of bias made using the Cochrane risk of
bias tool.
A cost-effectiveness analysis will be undertaken through a pro-
cess of cost effectiveness literature review, effectiveness data from
the study (WP3 and WP4), costing of multicomponent support group
interventions and the online intervention, modelling of cost-
effectiveness over the lifetime, assessment of uncertainty, and gener-
ation of an estimate of cost-effectiveness. This will be exploratory in
the case of WP4 as the data are from a feasibility trial.
As the intervention develops, we plan to investigate using social
return on investment (SROI), which is widely used in public health to
evaluate services and interventions. SROI allows us to take account of
a wide range of stakeholders and offers the opportunity to consider
the outcomes for a much broader set of stakeholders than more tradi-
tional methods used in health economics. We will follow the Cabinet
Office guide for SROI as recommended by the SROI Network and the
New Economics Foundation (NEF).
Hard outcomes are reported widely using traditional methods of
evaluation and are easier to report as they use numerical data to dem-
onstrate differences. Soft outcomes are more difficult to report, as
they often depend on subjective measures such as changes in confi-
dence or behaviour. SROI offers the opportunity to report hard and
soft outcomes in tandem, resulting in an evaluation that reveals the
difference an intervention can make not just in figures but in terms of
the difference the intervention has made to the person, community,
and wider stakeholders.
The additional challenges of undertaking economic evaluation of
dementia have been noted in the literature.37 We will use experience
from our previous work in the field of dementia economics, this litera-
ture, and data from other WSs to inform the economic modelling
component of this study.
3 | DISCUSSION
3.1 | Ethical considerations
The study has been approved by the University College London
Research Ethics Committee. Informed consent will be obtained and
data collected in a variety of ways according to the participants' pref-
erences, either via (a) face-to-face written/recorded responses,
(b) virtually via videoconferencing and teleconferencing software, or
(c) questionnaire/scale data and consent forms completed online.
Appropriate written or oral translation of consent forms and research
materials will be provided where the first language of the participants
is not English. In accordance with the Mental Capacity Act (2005), all
participants will be considered by the researcher as to whether they
are able to understand the research information that is presented to
them and retain this information in order to weigh up whether they
would like to take part. Participants with a diagnosis of a dementia
taking part in the RDS Impact study will have capacity to consent.
The interview data collected in person or via tele/videoconfer-
encing will be recorded and automatically transcribed via the
GoToMeeting platform, a GDPR-compliant online meeting, desk-
top sharing, and videoconferencing software package that enables
participants to meet with researchers via the Internet in real time.
Questionnaire and scale data will be collected online via a GDPR-
compliant web-based survey tool, or in hard copy format. All data
will be uploaded to the UCL Data Safe Haven, which has been cer-
tified to the ISO27001 information security standard. The reposi-
tory uses a “walled garden” approach, where the data are stored,
processed, and managed within the security of the system,
avoiding the complexity of assured endpoint encryption. A file
transfer mechanism enables information to be transferred into the
walled garden simply and securely. Where possible, data will be
analysed within the repository. Where specialist software is
required and not supported by UCL Data Safe Haven, a pseudo-
nymised version of the data will be downloaded to institutional
servers and analysed locally, before being reuploaded to the Data
Safe Haven. Hard copy data collected outside of UCL will be trans-
ported on a quarterly basis to the Dementia Research Centre, UCL,
and stored securely.
The data we are collecting for the RDS Impact study centres on
asking individuals about their lived experience of a dementia. The
research team have considered the risks involved with asking ques-
tions from which emotional responses could arise and have set out
robust distress and safeguarding protocols to manage the risks
involved. Participant will additionally be made aware of their right to
withdraw from the study at any time without their clinical, legal,
and/or support needs being compromised.
3.2 | Patient and public involvement (PPI)
RDS members contributed to sketching out the motivations and the-
oretical background for this study. Co-applicant Roberta McKee-
Jackson, who has been a member of the PCA Support Group since
2007 and Bereaved Carers Support Group since 2017, has
emphasised support groups' provision not only of “support, advice,
guidance, and encouragement” but notably also “respect,” achieved
through the “opportunities to share in a safe environment, develop
new friendships and a support network of peers, and to access spe-
cialist consultants, nurses and clinical staff.” McKee-Jackson will co-
lead PPI during the research programme with Crutch, who previ-
ously led on PPI for the Queen Square Dementia Biomedical
Research Unit.
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We will continue to encourage RDS members who are PLWD
and carers to be involved through (a) contributing and directing con-
tent of meetings, websites, newsletters; (b) co-writing advice sheets,
eg, FTD Carer Stories, The Stages of PCA; (c) contributions to the
RDS Advisory Committee and RDS Governance Subcommittees which
currently include FTD and PCA members; and (d) co-designing the
study alongside the research team to reach consensus about the mea-
sures used in the main interviews.
4 | CONCLUSION
The study aims to investigate the impact and reach of mul-
ticomponent support offered and delivered to people living with a
rare form of dementia. The study will capture information through a
combination of longitudinal interviews, questionnaires and scales, and
novel creative data collection methods. The notion of “impact” in the
context of support for rare dementias will involve theoretical develop-
ment, novel measures and methods of support interventions, and
health economic analyses.
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